Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia is a research paper published in Leukemia (2020). On theSindex it has a DataRank of 0.705. It has been cited 109 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.705
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30 CA008748
NCATS NIH HHS
Grant: KL2 TR001865
NCI NIH HHS
Grant: K08 CA248966
NCATS NIH HHS
Grant: UL1 TR001866
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 5KL2TR001865-10
Institutional Career Development Core
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 1K08CA248966-01
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment
U.S. Department of Health & Human Services | NIH | National Cancer Institute
FWCI
2.39
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals